Your browser doesn't support javascript.
loading
Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
Eusebi, Leonardo H; Telese, Andrea; Cirota, Giovanna G; Haidry, Rehan; Zagari, Rocco M; Bazzoli, Franco; Ford, Alexander C.
Afiliación
  • Eusebi LH; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Telese A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Cirota GG; Department of Gastroenterology, University College London Hospital (UCLH), London, UK.
  • Haidry R; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Zagari RM; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Bazzoli F; Department of Gastroenterology, University College London Hospital (UCLH), London, UK.
  • Ford AC; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Aliment Pharmacol Ther ; 53(9): 968-976, 2021 05.
Article en En | MEDLINE | ID: mdl-33705573
ABSTRACT

BACKGROUND:

Gastro-oesophageal reflux is considered the main risk factor for Barrett's oesophagus. The role of other potential risk factors for the development of Barrett's oesophagus in patients with gastro-oesophageal reflux symptoms is controversial.

AIMS:

To perform a systematic review and meta-analysis examining risk factors in development of Barrett's oesophagus.

METHODS:

Medline, Embase and Embase Classic were searched (until December 2020) to identify cross-sectional studies reporting prevalence of Barrett's oesophagus based on presence of one or more proposed risk factors in individuals with gastro-oesophageal reflux symptoms. Prevalence of Barrett's oesophagus was compared according to presence or absence of each risk factor in individuals with gastro-oesophageal reflux symptoms.

RESULTS:

Of 7164 citations evaluated, 13 studies reported prevalence of Barrett's oesophagus in 11 856 subjects. Pooled prevalence of histologically confirmed Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms in all studies was 7.0% (95% CI 4.8% to 9.6%). Prevalence was higher in subjects with hiatal hernia (OR 2.74; 95% CI 1.58 to 4.75) and in those who drank alcohol (OR 1.51; 95% CI 1.17 to 1.95). Other features including non-steroidal anti-inflammatory drugs and/or aspirin use (OR 1.19; 95% CI 1.00 to 1.42), smoking (OR 1.14; 95% CI 0.96 to 1.35) or obesity (OR 1.10; 95% CI 0.92 to 1.33) were not significantly associated with Barrett's oesophagus.

CONCLUSIONS:

The prevalence of Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms was higher in those who drank alcohol, although this association was modest. The strongest association found was between hiatal hernia and Barrett's oesophagus. Other potential risk factors assessed in this study did not appear to be associated with presence of Barrett's oesophagus among individuals with gastro-oesophageal symptoms.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Esofagitis Péptica / Reflujo Gastroesofágico Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Esofagitis Péptica / Reflujo Gastroesofágico Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article